Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis

The global burden of pediatric severe respiratory illness is substantial, and influenza viruses contribute to this burden. Systematic surveillance and testing for influenza among hospitalized children has expanded globally over the past decade. However, only a fraction of the data has been used to e...

Full description

Saved in:
Bibliographic Details
Published inPLoS medicine Vol. 13; no. 3; p. e1001977
Main Authors Lafond, Kathryn E, Nair, Harish, Rasooly, Mohammad Hafiz, Valente, Fátima, Booy, Robert, Rahman, Mahmudur, Kitsutani, Paul, Yu, Hongjie, Guzman, Guiselle, Coulibaly, Daouda, Armero, Julio, Jima, Daddi, Howie, Stephen R C, Ampofo, William, Mena, Ricardo, Chadha, Mandeep, Sampurno, Ondri Dwi, Emukule, Gideon O, Nurmatov, Zuridin, Corwin, Andrew, Heraud, Jean Michel, Noyola, Daniel E, Cojocaru, Radu, Nymadawa, Pagbajabyn, Barakat, Amal, Adedeji, Adebayo, von Horoch, Marta, Olveda, Remigio, Nyatanyi, Thierry, Venter, Marietjie, Mmbaga, Vida, Chittaganpitch, Malinee, Nguyen, Tran Hien, Theo, Andros, Whaley, Melissa, Azziz-Baumgartner, Eduardo, Bresee, Joseph, Campbell, Harry, Widdowson, Marc-Alain
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 24.03.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The global burden of pediatric severe respiratory illness is substantial, and influenza viruses contribute to this burden. Systematic surveillance and testing for influenza among hospitalized children has expanded globally over the past decade. However, only a fraction of the data has been used to estimate influenza burden. In this analysis, we use surveillance data to provide an estimate of influenza-associated hospitalizations among children worldwide. We aggregated data from a systematic review (n = 108) and surveillance platforms (n = 37) to calculate a pooled estimate of the proportion of samples collected from children hospitalized with respiratory illnesses and positive for influenza by age group (<6 mo, <1 y, <2 y, <5 y, 5-17 y, and <18 y). We applied this proportion to global estimates of acute lower respiratory infection hospitalizations among children aged <1 y and <5 y, to obtain the number and per capita rate of influenza-associated hospitalizations by geographic region and socio-economic status. Influenza was associated with 10% (95% CI 8%-11%) of respiratory hospitalizations in children <18 y worldwide, ranging from 5% (95% CI 3%-7%) among children <6 mo to 16% (95% CI 14%-20%) among children 5-17 y. On average, we estimated that influenza results in approximately 374,000 (95% CI 264,000 to 539,000) hospitalizations in children <1 y-of which 228,000 (95% CI 150,000 to 344,000) occur in children <6 mo-and 870,000 (95% CI 610,000 to 1,237,000) hospitalizations in children <5 y annually. Influenza-associated hospitalization rates were more than three times higher in developing countries than in industrialized countries (150/100,000 children/year versus 48/100,000). However, differences in hospitalization practices between settings are an important limitation in interpreting these findings. Influenza is an important contributor to respiratory hospitalizations among young children worldwide. Increasing influenza vaccination coverage among young children and pregnant women could reduce this burden and protect infants <6 mo.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-4
ObjectType-Undefined-1
content type line 23
ObjectType-Review-2
ObjectType-Article-3
PMCID: PMC4807087
Membership of the GRIPP Working Group is provided in the Acknowledgments.
Conceived and designed the experiments: KEL HN MAW. Performed the experiments: KEL MW EAB MAW. Analyzed the data: KEL HN EAB MAW. Contributed reagents/materials/analysis tools: KEL HN MW. Wrote the first draft of the manuscript: KEL. Contributed to the writing of the manuscript: MAW. Enrolled patients: MHR FV RB MR PK HY GG DC JA DJ SH WA RM MCha ODS GOE ZN AC JMH DEN RC PN AB AA MvH RO TN MV VM MChi THN AT GRIPP-WG. Agree with the manuscript’s results and conclusions: KEL HN MHR FV RB MR PK HY GG DC JA DJ SRCH WA RM MCha ODS GOE ZN AC JMH DEN RC PN AB AA MvH RO TN MV VM MChi THN AT MW EAB JB HC MAW GRIPP-WG. All authors have read, and confirm that they meet, ICMJE criteria for authorship.
We have read the journal's policy and have the following competing interests: DEN has participated on an influenza advisory board for Novartis. RB works with all major manufacturers of influenza vaccines in an advisory capacity, as a researcher on vaccines and as presenter of academic info at conferences, receiving support to travel and attend such conferences. The authors have declared that no other competing interests exist.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1001977